Oxidative stress and antioxidants in interstitial lung disease (ILD). The limited number of ILD patients necessitates multicenter trials to obtain enough power to reach clinically relevant data. The specific fibrotic toxicity of O2 might be a lead in the development of new therapies and of suggesting optimal antioxidant dietary regimes. A. Bast. (PubMed) Curr Opin Pulm Med. 2010 Sep (Also see: Oxidative Stress)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Oxidative stress and antioxidants in interstitial lung disease (ILD)
No replies to this topic